Article
Differential effect of cryopreservation on natural killer cell and lymphokine-activated killer cell activities.
Transfusion - 1 Aug 1993
Martí F, Miralles A, Peiró M, Amill B, de Dalmases C, Piñol G, Rueda F, García J
Abstract excerpt
The use of lymphokine-activated killer (LAK) cell therapy in delayed treatment requires the use of cryopreserved effector cells. The purpose of this study was to determine the optimal cryopreservation protocol for the maintenance of cytotoxic activity in mononuclear cells (MNCs). MNCs were cryopr...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
